All cancer types
Results
Phase 2
This study looked at a drug called AZD4547 for oesophageal (food pipe), stomach or breast cancer that has extra copies of the FGFR gene.
It was open for people to join between 2012 and 2017, and the team first published results in 2016.
Recruitment start: 2 September 2012
Recruitment end: 8 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof David Cunningham
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
The Royal Marsden NHS Foundation Trust
Last reviewed: 7 July 2020
CRUK internal database number: 10414
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
